Ultragenyx Reports First Quarter 2020 Financial Results and Corporate Update
Go back to Ultragenyx Reports First Quarter 2020 Financial Results and Corporate Update| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 15.62 +0.97 (6.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.65 | 52 Week High | $117.12 | |||
| Open | $14.78 | 52 Week Low | $46.52 | |||
| Day High | $16.12 | P/E | N/A | |||
| Day Low | $14.48 | EPS | $-1.97 | |||
| Volume | 8,127,267 | |||||
